Companies/KR/260660

알리코제약(주) · KOREA ARLICO PHARM CO.,LTD.

Income flow

Annual
260660 ANNUAL Income StatementPeriod 2025-12-31Source ANNUAL
Net salesKRW 201B+6% Y/YRevenueKRW 201B+6% Y/YGross profitKRW 104B+5% Y/YCost of revenueKRW 97BOperating profitKRW 989MOperating expensesKRW 103BOperating expensesKRW 103B

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Capital & dividends

Stock splits
  1. 1.5:12021-06-15
  2. 1.05:12020-12-29